ABSTRACT
Cranial irradiation of primary or metastatic lesions is frequent, historically with 3D-conformal radiation therapy and now with stereotactic radiosurgery and intensity modulation. Evolution of radiotherapy technique is concomitant to systemic treatment evolution permitting long time survival. Thus, physicians have to face underestimated toxicities on long-survivor patients and unknown toxicities from combination of cranial radiotherapy to new therapeutics as targeted therapies and immunotherapies. This article proposes to develop these toxicities, without being exhaustive, to allow a better apprehension of cranial irradiation in current context.
Subject(s)
Cranial Irradiation/adverse effects , Alopecia/etiology , Cancer Survivors , Cataract/etiology , Cognition Disorders/etiology , Cranial Irradiation/methods , Disorders of Excessive Somnolence/etiology , Dry Eye Syndromes/etiology , Epilepsy/etiology , Humans , Hypothalamic Diseases/etiology , Hypothalamo-Hypophyseal System/radiation effects , Immunotherapy/adverse effects , Meningeal Carcinomatosis/etiology , Migraine Disorders/etiology , Molecular Targeted Therapy/adverse effects , Olfaction Disorders/etiology , Radiosurgery/methods , Radiotherapy, Conformal/trends , Radiotherapy, Intensity-Modulated/trends , Syndrome , Taste Disorders , Xerostomia/etiologyABSTRACT
BACKGROUND: This study was to assess the rate of radiotherapy (RT) utilization according to the modality in South Korea to identify the implications of contemporary RT patterns. METHODS: We collected information from claims and reimbursement records of the National Health Insurance Service from 2010 to 2019. We classified the location of each institution as capital (Seoul, Incheon, and Gyeonggi-do) and non-capital areas. RESULTS: The rate of RT utilization in total cancer patients nationwide was 24.5% in 2010, which consistently has increased to 36.1% in 2019 (annual increase estimate [AIE], 4.5%). There was an abrupt increase in patients receiving intensity-modulated RT (IMRT), with an AIE of 33.5%, and a steady decline in patients receiving three-dimensional conformal RT (3DCRT), with an AIE of -7.1%. The commonest RT modality was IMRT (44.5%), followed by 3DCRT and stereotactic RT (SRT) (37.2% and 13.5%) in 2019. An increasing trend of advanced RT (such as IMRT and SRT) utilization was observed regardless of the region, although the AIE in the capital areas was slightly higher than that in non-capital areas. CONCLUSION: The utilization of overall RT application and especially of advanced modalities remarkably increased from 2010 to 2019. We also found gaps in their AIEs between capital and non-capital areas. We should ensure that advanced RT is accessible to all cancer patients across South Korea.
Subject(s)
Neoplasms/radiotherapy , Radiotherapy/methods , Radiotherapy/statistics & numerical data , Aged , Databases, Factual , Humans , Male , Middle Aged , National Health Programs , Neoplasms/epidemiology , Radiosurgery/statistics & numerical data , Radiosurgery/trends , Radiotherapy/trends , Radiotherapy, Conformal/statistics & numerical data , Radiotherapy, Conformal/trends , Radiotherapy, Intensity-Modulated/statistics & numerical data , Radiotherapy, Intensity-Modulated/trends , Republic of KoreaABSTRACT
For decades, radiotherapy with two opposing photon beams has been the standard technique used to cover the flank target volume in paediatric patients with renal tumours. Nowadays, many institutes are implementing advanced radiotherapy techniques that spare healthy tissue. To decrease the radiotherapy dose to healthy structures while preserving oncological efficacy, the conventional approach of flank irradiation has been adapted into a guideline for highly conformal flank target-volume delineation by paediatric radiation oncologists and representatives of the International Society of Paediatric Oncology's Renal Tumour Study Group (SIOP-RTSG) board during four live international consensus meetings. The consensus was refined by delineation exercises and videoconferences by ten collaborating paediatric radiation oncologists. The final guideline includes eight chronological steps to generate the tumour bed and clinical, internal, and planning target volumes, and it describes the optional use of surgical clips to optimise treatment planning. This guideline will be added into the radiotherapy guideline of the UMBRELLA SIOP-RTSG protocol for paediatric renal tumours to improve international consistency of highly conformal flank target-volume delineation.
Subject(s)
Kidney Neoplasms/radiotherapy , Organ Sparing Treatments/methods , Radiotherapy, Conformal , Child , Consensus , Humans , Kidney Neoplasms/pathology , Practice Guidelines as Topic , Radiologic Health , Radiotherapy, Conformal/methods , Radiotherapy, Conformal/trendsABSTRACT
Treatment planning is the process where the prescription of the radiation oncologist is translated into a deliverable treatment. With the complexity of contemporary radiotherapy, treatment planning cannot be performed without a computerized treatment planning system. Proton therapy (PT) enables highly conformal treatment plans with a minimum of dose to tissues outside the target volume, but to obtain the most optimal plan for the treatment, there are a multitude of parameters that need to be addressed. In this review areas of ongoing improvements and research in the field of PT treatment planning are identified and discussed. The main focus is on issues of immediate clinical and practical relevance to the PT community highlighting the needs for the near future but also in a longer perspective. We anticipate that the manual tasks performed by treatment planners in the future will involve a high degree of computational thinking, as many issues can be solved much better by e.g. scripting. More accurate and faster dose calculation algorithms are needed, automation for contouring and planning is required and practical tools to handle the variable biological efficiency in PT is urgently demanded just to mention a few of the expected improvements over the coming 10 years.
Subject(s)
Algorithms , Forecasting , Proton Therapy/methods , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Conformal/methods , Automation , Data Accuracy , Humans , Monte Carlo Method , Needs Assessment , Organs at Risk/diagnostic imaging , Proton Therapy/trends , Radiotherapy Planning, Computer-Assisted/trends , Radiotherapy, Conformal/trends , Relative Biological Effectiveness , Time FactorsABSTRACT
Image guidance has been playing a decisive role throughout the history of radiotherapy, but developments in 3D-and 4D imaging data acquisition using computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) have significantly boosted the precision of conformal radiotherapy. An overarching aim of radiotherapy is conforming the treatment dose to the tumor in order to optimally limit a high radiation dose outside the target. Stereotactic, intensity modulated, and adaptive radiotherapy are all largely based on appropriately using imaging information both before and during treatment delivery using on-board imaging devices. While pretreatment imaging for planning has reached a very high level in the past two decades, the next step will be to further refine and accelerate imaging during treatment delivery, resulting in adaptation of the dose fluence during a patient's treatment in various scenarios, some of which are discussed in this article.
Subject(s)
Imaging, Three-Dimensional , Magnetic Resonance Imaging , Radiotherapy, Conformal , Tomography, X-Ray Computed , Humans , Positron-Emission Tomography , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted , Radiotherapy, Conformal/trendsABSTRACT
BACKGROUND: This study aimed to assess the recent changes of radiation therapy (RT) modalities in Korea. In particular, we focused on intensity-modulated radiation therapy (IMRT) utilization as the main index, presenting the application status of advanced RT. METHODS: We collected information from the Korean Health and Insurance Review and Assessment Service data based on the National Health Insurance Service claims and reimbursements records by using treatment codes from 2010 to 2016. We classified locating region of each institution as capital vs. non-capital areas and metropolitan vs. non-metropolitan areas to assess the regional difference in IMRT utilization in Korea. RESULTS: IMRT use has been steadily increased in Korea, with an annual increase estimate (AIE) of 37.9% from 2011 to 2016 (P < 0.001) resulting in IMRT being the second most common RT modality following three-dimensional conformal radiotherapy. In general, an increasing trend of IMRT utilization was observed, regardless of the region. The rate of AIE in the capital areas or metropolitan areas was higher than that in non-capital areas or non-metropolitan areas (40.7% vs. 31.9%; P < 0.001 and 39.7% vs. 29.4%; P < 0.001, respectively). DISCUSSION: The result of our survey showed that IMRT has become one of the most common RT modalities. IMRT is becoming popular in both metropolitan and non-metropolitan areas, while metropolitan area has faster AIE possibly due to concentration of medical resources and movement of advanced patients.
Subject(s)
Radiotherapy, Intensity-Modulated/trends , Brachytherapy/trends , Databases, Factual , Humans , National Health Programs , Radiosurgery/trends , Radiotherapy, Conformal/trends , Republic of Korea , Surveys and QuestionnairesABSTRACT
PURPOSE: Limited data exist regarding the range of heart doses received in routine practice with radiation therapy (RT) for breast cancer in the United States today and the potential effect of the continual assessment of the cardiac dose on practice patterns. METHODS AND MATERIALS: From 2012 to 2015, 4688 patients with breast cancer treated with whole breast RT at 20 sites participating in a state-wide consortium were enrolled into a registry. The importance of limiting the cardiac dose has been emphasized in the consortium since 2012, and the mean heart dose (MHD) has been reported by each institution since 2014. The effects on the MHD were estimated for both conventional and accelerated fractionation using regression models, with technique (intensity modulated RT [IMRT] vs 3-dimensional conformal RT), deep inspiration breath hold use, patient position (supine vs prone), nodal RT (if delivered), and boost (yes vs no) as covariates. RESULTS: For left-sided breast cancer treated with conventional fractionation, the median MHD in 2012 was 2.19 Gy versus 1.65 Gy in 2015 (P<.001). The factors that significantly increased the MHD for conventional fractionation were increased separation relative to 22 cm (1.5%/1 cm), supraclavicular or infraclavicular nodal RT (17.1%), internal mammary nodal RT (40.7%), use of a boost (20.9%), treatment year before 2015 (7.7%), and use of IMRT (20.8%). For left-sided BC treated with accelerated fractionation, the median MHD in 2012 was 1.70 Gy versus 1.22 Gy in 2015 (P<.001). The factors that significantly increased the MHD for accelerated fractionation were separation (1.7%/1 cm), use of a boost (20.0%), year before 2015 (8.5%), and use of IMRT (19.2%). The factors for both conventional fractionation and accelerated fractionation that significantly reduced the MHD were the use of deep inspiration breath hold and prone positioning. CONCLUSIONS: The MHD for left-sided breast cancer decreased during a recent 4-year period, coincident with an increased focus on cardiac sparing in the radiation oncology community in general and a state-wide consortium specifically. These data suggest a positive effect of systematically monitoring the heart dose delivered.
Subject(s)
Heart/radiation effects , Radiation Injuries/prevention & control , Radiation Oncology/trends , Radiotherapy, Conformal/methods , Unilateral Breast Neoplasms/radiotherapy , Breath Holding , Dose Fractionation, Radiation , Female , Humans , Organs at Risk/radiation effects , Patient Positioning/methods , Radiotherapy Dosage , Radiotherapy, Adjuvant/adverse effects , Radiotherapy, Adjuvant/methods , Radiotherapy, Adjuvant/trends , Radiotherapy, Conformal/adverse effects , Radiotherapy, Conformal/trends , Radiotherapy, Intensity-Modulated/adverse effects , Radiotherapy, Intensity-Modulated/methods , Radiotherapy, Intensity-Modulated/trends , Regression Analysis , Time Factors , United StatesSubject(s)
Clinical Competence/standards , Health Physics/trends , Radiation Oncology/trends , Radiotherapy Planning, Computer-Assisted/trends , Radiotherapy, Conformal/trends , Health Physics/standards , Humans , Professional Role , Radiation Oncology/standards , Radiotherapy Planning, Computer-Assisted/standards , Radiotherapy, Conformal/standardsSubject(s)
Antineoplastic Agents, Hormonal/therapeutic use , Brachytherapy/trends , Prostatectomy/trends , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/therapy , Radiotherapy, Conformal/trends , Clinical Decision-Making , Combined Modality Therapy/trends , Humans , Male , Neoplasm Grading/trends , Watchful Waiting/trendsABSTRACT
Up to 12% of European men aged 55-69 years diagnosed with prostate cancer have high-risk disease and thus are at increased risk of mortality. There remains a lack of consensus on definitive treatment for prostate cancer, although both radiation therapy and radical prostatectomy are frequently utilized. Furthermore, the different types of radiation and surgical options also increase the complexity of deciding on a single treatment, as does the use of multimodal treatment plans. Here, we provide an overview of radiation therapy and radical prostatectomy in treating high-risk prostate cancer.
Subject(s)
Brachytherapy/methods , Prostatectomy/methods , Radiotherapy, Conformal/methods , Aged , Brachytherapy/trends , Combined Modality Therapy/methods , Combined Modality Therapy/trends , Evidence-Based Medicine , Humans , Male , Middle Aged , Prostatectomy/trends , Radiotherapy, Conformal/trends , Risk Assessment , Treatment OutcomeABSTRACT
Basal cell carcinoma represents is most common tumor in fair-skinned individuals. In Germany, age-standardized incidence rates are 63 (women) and 80 (men) per 100,000 population per year. Early lesions may be difficult to diagnose merely on clinical grounds. Here, noninvasive diagnostic tools such as optical coherence tomography and confocal laser scanning microscopy may be helpful. The clinical diagnosis is usually confirmed by histology. Standard therapy consists of complete excision with thorough histological examination, either by means of micrographic surgery or, depending on tumor size and location as well as infiltration, using surgical margins of 3-5 mm or more. In particular, multiple basal cell carcinomas (such as in Gorlin-Goltz syndrome) and locally advanced as well as rarely also metastatic basal cell carcinoma may pose a therapeutic challenge. In superficial basal cell carcinoma, nonsurgical therapies such as photodynamic therapy or topical agents may be considered. In case of locally advanced or metastatic basal cell carcinoma, an interdisciplinary tumor board should issue therapeutic recommendations. These include radiation therapy as well as systemic therapy with a hedgehog inhibitor.
Subject(s)
Carcinoma, Basal Cell/diagnosis , Carcinoma, Basal Cell/therapy , Dermatology/trends , Skin Neoplasms/diagnosis , Skin Neoplasms/therapy , Antineoplastic Agents/administration & dosage , Combined Modality Therapy , Dermatologic Surgical Procedures/trends , Dermoscopy/trends , Diagnosis, Differential , Evidence-Based Medicine , Humans , Photochemotherapy/trends , Radiotherapy, Conformal/trends , Tomography, Optical Coherence/trends , Treatment OutcomeABSTRACT
Radiotherapy (RT) remains the principal component of glioma treatment, and three-dimensional conformal RT (3DCRT) is the current standard of RT delivery. Advances in imaging and in RT technology have enabled more precise treatment to defined targets combined with better means of avoiding critical normal structures, and this is complemented by intensive quality assurance, which includes on-treatment imaging. The refinements of 3DCRT include intensity modulated RT (IMRT), arcing IMRT, and high-precision conformal RT, formerly described as "stereotactic," which can be delivered using a linear accelerator or other specialized equipment. Although proton therapy uses heavy charged particles, the principal application can also be considered as refinement of 3DCRT. The technologies generally improve the dose differential between the tumor and normal tissue and enable more dose-intensive treatments. However, these have not translated into improved survival outcome in patients with low- and high-grade gliomas. More intensive altered fractionation regimens have also failed to show survival benefit. Nevertheless, novel technologies enable better sparing of normal tissue and selective avoidance of critical structures, and these need to be explored further to improve the quality of life of patients with gliomas. Principal clinical advance in RT has been the recognition that less intensive treatments are beneficial for patients with adverse prognosis high-grade gliomas. We conclude that the principal gain of modern RT technology is more likely to emerge as a reduction in treatment related toxicity rather than as an improvement in overall survival; the optimal avoidance strategies remain to be defined.
Subject(s)
Glioma/radiotherapy , Radiotherapy, Conformal/methods , Glioma/mortality , Glioma/pathology , Humans , Imaging, Three-Dimensional/methods , Neoplasm Grading , Radiation Oncology/instrumentation , Radiation Oncology/methods , Radiation Oncology/trends , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy Planning, Computer-Assisted/trends , Radiotherapy, Conformal/adverse effects , Radiotherapy, Conformal/trends , Radiotherapy, Intensity-Modulated/adverse effects , Radiotherapy, Intensity-Modulated/methods , Treatment OutcomeABSTRACT
Conventional treatment options for clinically localized, low-risk prostate cancer include radical prostatectomy, external-beam radiotherapy (EBRT) and low-dose-rate brachytherapy. Advances in image-guided radiotherapy (IGRT) since the 1980s, the development of intensity-modulated radiotherapy (IMRT) during the 1990s and evidence from radiobiological models--which support the use of high doses per fraction--have developed alongside novel advanced radiotherapy modalities that include high-dose-rate brachytherapy (HDR-BT), stereotactic body radiotherapy (SBRT) and proton beam therapy. The relationship between the outcomes of and toxicities experienced by patients with prostate cancer treated with HDR-BT, SBRT and particle-beam therapy should provide urologists and oncologists an understanding of the continually evolving technology in prostate radiotherapy. On the basis of published evidence, conventionally fractionated EBRT with IMRT is considered the standard of care over conventional 3D conformal radiotherapy, whereas HDR-BT boost is an acceptable treatment option for selected patients with intermediate-risk and high-risk prostate cancer. SBRT and proton therapy should not be used for patients (regardless of disease risk group) outside the setting of a clinical trial. Finally, comparative effectiveness research should be conducted to provide a framework for evaluating advanced radiotherapy technologies by comparing the benefits and harms of available therapeutic options to optimize the risk:benefit ratio and improve cost effectiveness.
Subject(s)
Prostatic Neoplasms/radiotherapy , Prostatic Neoplasms/surgery , Radiosurgery/trends , Radiotherapy, Image-Guided/trends , Animals , Humans , Male , Prostatic Neoplasms/diagnosis , Radiosurgery/methods , Radiotherapy, Conformal/methods , Radiotherapy, Conformal/trends , Radiotherapy, Image-Guided/methodsSubject(s)
Neoplasms/radiotherapy , Radiation Injuries/etiology , Radiation Injuries/prevention & control , Radiosurgery/adverse effects , Radiosurgery/trends , Radiotherapy, Conformal/adverse effects , Radiotherapy, Conformal/trends , Forecasting , Humans , X-Ray Therapy/adverse effects , X-Ray Therapy/trendsABSTRACT
Organ motion is a substantial concern in the treatment of thoracic tumours using radiotherapy. A number of technologies have evolved in order to address this concern in both the fields of CT imaging and radiation delivery. This review paper investigates the technologies which have been developed for the delivery of radiotherapy as well as the accuracy and workload implications of their use. Treatment techniques investigated include: breath hold, breath gating, robotic compensation and MLC manipulation. Each technique has its own advantages and drawbacks in regards to accuracy, treatment time, linac alterations and workload. Further, some treatment techniques have specific requirements for what kind of CT scans needs to be used in the planning process. This, along with the aforementioned considerations, could influence the decision as to implement some of these treatment techniques in the clinic.
Subject(s)
Artifacts , Imaging, Three-Dimensional/methods , Neoplasms/radiotherapy , Radiotherapy, Conformal/methods , Radiotherapy, Image-Guided/methods , Respiratory-Gated Imaging Techniques/methods , Tomography, X-Ray Computed/methods , Humans , Imaging, Three-Dimensional/trends , Motion , Neoplasms/diagnostic imaging , Radiotherapy, Conformal/trends , Radiotherapy, Image-Guided/trends , Respiratory-Gated Imaging Techniques/trends , Tomography, X-Ray Computed/trendsABSTRACT
Prostate cancer represents the most frequently diagnosed malignant tumor in Germany. Primary radiotherapy is one of the two recommended curative treatment options for this disease. There are two types of radiotherapy: external beam radiotherapy and interstitial brachytherapy. Technical developments during the last two decades have made it possible to achieve improved chances of being cured of tumors and improved relief from disease-related symptoms for patients at all tumor stages. Moreover, treatment can be administered with a reduced rate of side effects. Results of classical 3D conformal radiotherapy as well as modern radiation therapy techniques are comprehensively presented including the concept of hypofractionation with results from available randomized trials. After comprehensive assessment of all relevant risk factors, recommendations for the type of treatment must be based on a multidisciplinary approach.
Subject(s)
Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/radiotherapy , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Conformal/methods , Radiotherapy, Conformal/trends , Germany , Humans , MaleABSTRACT
Technical improvements in computed tomography and magnetic resonance imaging as well as the wider availability of biological imaging have facilitated the implementation of high-precision 3-dimensional conformal and intensity-modulated radiotherapy (RT) in head and neck cancer. The integration of recent advances in functional and molecular imaging has already improved RT delivery, response prediction, and follow-up. Rational clinical use of all modalities should be encouraged, especially in the setting of imaging-intensive investigational RT protocols such as adaptive therapy. An expanded development of imaging markers that can predict radioresistance or outcome could further customize treatment. The continued successful use of innovative imaging in routine clinical practice will ultimately depend on well-designed clinical studies with adequate follow-up.
Subject(s)
Head and Neck Neoplasms/diagnosis , Head and Neck Neoplasms/radiotherapy , Molecular Imaging/trends , Radiotherapy, Conformal/trends , Radiotherapy, Image-Guided/trends , Humans , Prognosis , Treatment OutcomeABSTRACT
Radiotherapy is an important and well integrated part in modern treatment concepts for cancer of the lung and pleura. Thanks to technical progress in the last years radiotherapy has managed to prove its role in all stages of lung cancers and has opened a spectrum of new treatment options. Stereotactic radiotherapy of the early NSCLC has become the standard treatment for radically inoperable patients. It provides better local control rates than traditional conventionally fractionated radiotherapy. In stage III NSCLC, simultaneous radiochemotherapy is an effective option with equal results compared to surgery. The standard treatment for limited disease SCLC is primary simultaneous radiochemotherapy. All patients with good response after primary treatment profit from prophylactic cranial irradiation. Adjuvant radiotherapy is a component of the trimodal treatment for curative approaches in patients with pleura mesothelioma. Palliative radiotherapy is the standard treatment for brain metastases, bone metastases and compression or obstruction from thoracal tumour mass.